Shuanglu Pharmaceutical Co., Ltd.: beconable's expectation of raising price falls short of the new contract and redistributing profit share

Shuanglu Pharmaceutical Co., Ltd (002038 SZ) failed to raise the price of its main product, beco It has been determined that the price of the new agency sales contract remains unchanged, and some clinical expenses are transferred to dealers Insiders of the company told the big smart news agency that the change of cost bearing party has improved the company's profit sharing Beconone, commonly known as compound coenzyme for injection, is the main product of Shuanglu pharmaceutical industry Its sales volume increased by about 70% in 2012 The sales volume is expected to be more than 500 million yuan, accounting for about 55% of the company's total revenue In the past few years, beikoneng has been exclusively distributed by Hainan Kangyong as the sole agent of Shuanglu pharmaceutical industry The five-year cooperation between the two sides expires in October this year Prior to that, Shuanglu pharmaceutical industry has recovered the market agency right of Hainan Kangyong in the past few years, and handed it over to several new agents Before that, Becco had a strong expectation of raising the price After the sales contract with the dealers expired in September, it was planned to raise the price in the signing of a new consignment agreement According to the research report issued by CSCI, Shuanglu pharmaceutical industry may adopt the strategy of raising the price 50% in two times, and the time of raising the price may also be advanced to the third quarter In May this year, Xu Mingbo, chairman and general manager of Shuanglu Pharmaceutical Co., Ltd., also said at the performance presentation meeting that after the expiration of the agency contract of beconor, the company's main product, due to the new GMP certification, price increase of raw materials, increase of labor cost and expiration of the contract and other factors, the price will be increased, and the regional agency will be considered comprehensively.